HTUPG Trademark

Trademark Overview


On Friday, January 11, 2019, a trademark application was filed for HTUPG with the United States Patent and Trademark Office. The USPTO has given the HTUPG trademark a serial number of 88258856. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 22, 2021. This trademark is owned by Harbin Medisan Pharmaceutical Co., Ltd.. The HTUPG trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pain relief medication; Medicines for the treatment of gastrointestinal diseases; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Protein arrays for diagnosing allergies, and cancer; Therapeutic pharmaceutical for the treatment of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Pharmaceutical preparations, namely, elixirs for the treatment of gastrointestinal, cancer, infection, neurologic...
htupg

General Information


Serial Number88258856
Word MarkHTUPG
Filing DateFriday, January 11, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 22, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2019

Trademark Statements


Goods and ServicesDrug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pain relief medication; Medicines for the treatment of gastrointestinal diseases; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Protein arrays for diagnosing allergies, and cancer; Therapeutic pharmaceutical for the treatment of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Pharmaceutical preparations, namely, elixirs for the treatment of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Dietary and nutritional supplements; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Dietetic foods for treating celiac disease and gastrointestinal disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment and prevention of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Capsules made from starch sold empty for pharmaceuticals; Biometallic compounds being a component in pharmaceutical preparations for treatment and prevention of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Biological preparations for the treatment and prevention of gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Transdermal patches for use in the treatment of musculoskeletal diseases; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Tumor suppressing agents; Nutraceuticals for the treatment of cardiovascular diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 2, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHarbin Medisan Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZone, Harbin 150025
CN

Party NameHarbin Medisan Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZone, Harbin 150025
CN

Trademark Events


Event DateEvent Description
Monday, February 22, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 22, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 22, 2020EXTENSION 2 GRANTED
Friday, May 22, 2020EXTENSION 2 FILED
Friday, May 22, 2020TEAS EXTENSION RECEIVED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019EXTENSION 1 GRANTED
Tuesday, December 17, 2019EXTENSION 1 FILED
Tuesday, December 17, 2019TEAS EXTENSION RECEIVED
Tuesday, July 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 21, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 1, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 12, 2019ASSIGNED TO LIE
Tuesday, March 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 26, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, March 26, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 26, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, March 26, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 26, 2019ASSIGNED TO EXAMINER
Saturday, February 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 15, 2019NEW APPLICATION ENTERED IN TRAM